Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Avid Bioservices Inc (CDMOP)

25.29   -0.41 (-1.6%) 10-31 14:57
Open: 25.7079 Pre. Close: 25.7
High: 25.82 Low: 25.29
Volume: 14,828 Market Cap: 207M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 25.831 - 26.005 26.005 - 26.149
Low: 24.956 - 25.126 25.126 - 25.266
Close: 25.043 - 25.317 25.317 - 25.544

Technical analysis

as of: 2020-10-30 4:29:45 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 31.06     One year: 32.00
Support: Support1: 25.29    Support2: 21.04
Resistance: Resistance1: 26.59    Resistance2: 27.40
Pivot: 26.52
Moving Average: MA(5): 26.09     MA(20): 26.65
MA(100): 26.08     MA(250): 25.62
MACD: MACD(12,26): -0.21     Signal(9): -0.07
Stochastic oscillator: %K(14,3): 32.75     %D(3): 34.99
RSI: RSI(14): 35.97
52-week: High: 28.44  Low: 17.51  Change(%): -5.2
Average Vol(K): 3-Month: 255  10-Days: 323

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
CDMOP has closed below the lower band by 10.6%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 66.5% wider than normal. The large width of the bands suggest high volatility as compared to CDMOP's normal range. The bands have been in this wide range for 0 bars. This is a sign that the current trend might continue.

Headline News

Tue, 01 Sep 2020
Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2020 and Recent Developments - GlobeNewswire

Mon, 31 Aug 2020
Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock - GlobeNewswire

Wed, 26 Aug 2020
Avid Bioservices Selected by Mapp Biopharmaceutical, Inc. for Clinical Development of Novel Human Monoclonal Antiviral Antibody - GlobeNewswire

Tue, 25 Aug 2020
Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2021 After Market Close on September 1, 2020 - GlobeNewswire

Thu, 20 Aug 2020
Oragenics Signs Process Development and Manufacturing Agreement With Avid Bioservices for Coronavirus Vaccine - BioSpace

Thu, 06 Aug 2020
Avid Bioservices Selected By Iovance Biotherapeutics to Lead Process Development Through CGMP Manufacturing of Novel IL-2 Analog, IOV-3001 - GlobeNewswire

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Outperform
Return on Equity: Outperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 56
Shares Float (M) 42
% Held by Insiders 4.83
% Held by Institutions
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -0.130
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 0.820
Profit Margin -3.68
Operating Margin -3.57
Return on Assets (ttm) -1.5
Return on Equity (ttm) -5.3
Qtrly Rev. Growth 66.5
Gross Profit (p.s.) 0.070
Sales Per Share 1.247
EBITDA (p.s.) 0.013
Qtrly Earnings Growth
Operating Cash Flow (M) 6
Levered Free Cash Flow (M) 3

Stock Valuations

PE Ratio -194.54
PEG Ratio
Price to Book value 30.84
Price to Sales 20.28
Price to Cash Flow 235.26

Stock Dividends

Dividend
Forward Dividend 2.620
Dividend Yield
Dividend Pay Date 2020-09-30
Ex-Dividend Date 2020-09-10
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.